Skip to content
40

tardyferon

Skip it

Brand-locked demand (top 5 brands take 100% of clicks) — this niche doesn't clear our bar today.

Market size 15Growth 25Conversion 98Competition 3Returns 100Price range 37Avg price 72Brand share 0Review moat 96Quality gap 38

Returns

Incredible0.0%

return rate — above 6% kills the launch gate

Conversion

Incredible17.4%

search→purchase rate — share of searches ending in a sale

Review moat

Incredible76.83

avg incumbent reviews — the moat a new listing must climb

Avg price

Good€14.69

avg listing price — sweet spot $15–$100

Quality gap

Okay4.5★

avg incumbent rating — lower means beatable quality

Price range

Okay€9.18–€18.35

cheapest to priciest tracked listing — scored on the share inside $15–$100

Growth

Bad-0.4%

90-day search growth — must beat 0% to launch

Market size

Bad€59K

€59K/yr · 23K searches

Competition

Bad97%

top-5 click share — a locked-up shelf

Brand share

Bad100%

top-5 brand share — brand-locked demand

Competition

The top 5 products capture 97% of clicks — a locked-up shelf that new listings rarely crack.

Brands

5 falling

Sellers

15

Top-5 brand share

100%

Open market

0%

  • Orifarm GmbH47%
  • kohlpharma GmbH22%
  • Tardyferon21%
  • Pierre Fabre Dermo Kosmetik GmbH7%
  • Healthing3%

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%15%€9K30%€18K45%€27K60%€36K101001K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)

All 6 tracked products in this niche — three views at once, no toggling.

Demand & seasonality

Weekly Amazon search volume, last 82 weeks — -0.4% search growth over the last 90 days.
700500Spike '25Prime Day '25Black Friday '25Spike '26JanFebMarAprMayJunJulAugSepOctNovDecJanFebMarAprMayJun

Peak months: Jul · busiest ÷ quietest = 1.6×

Reviews

What buyers praise and complain about, mined from review topics.

What buyers love

Eisen40%

“Eisen”

Qualität insgesamt20%

“Prima Produkt”

beworben Vs Tatsächliches Produkt20%

“Wie erwartet”

Effizienz7%

“So funktioniert das sehr gut für mich”

What buyers complain about

Säureregulator/Linderung von Magenschmerzen25%

“Ich vertrage sie leider nicht gut, nach der Einnahme habe ich Magenschmerzen und Verstopfung bekommen”

Nebenwirkungen25%

“Ist eine typische Nebenwirkung”

Eisen17%

“Vor 2 Monaten hatte ich eine Eiseninfusion im Krankenhaus, allerdings vertrug ich die nicht sonderlich gut”

Reguliert die Verdauung17%

“Von allen anderen Tabletten bekomme ich Magenprobleme”